19 November 2025 - In September Natalie McMurtry joined PHARMAC as our new Chief Executive. ...
12 November 2025 - PHARMAC will fund silver diamine fluoride for the treatment and prevention of tooth decay from 1 December ...
12 November 2025 - New Zealanders living with multiple sclerosis, breast cancer, eye conditions, and lung cancer will benefit from ...
6 November 2025 - PHARMAC is proposing changes to the Special Authority and Hospital Indication Restrictions criteria for four biologic ...
1 November 2025 - The November 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
21 October 2025 - Pharmac’s Pūahoaho Report provides the latest information about applications for medicines, vaccines, and related products that we’ve ...
20 October 2025 - PHARMAC is proposing changes to bring greater transparency and clarity to how medicine funding applications are ...
16 October 2025 - PHARMAC is removing unnecessary renewal requirements for selected Special Authority medicines and products, making it easier ...
1 October 2025 - New Zealanders living with, or at risk of, HIV could soon benefit from proposed changes to ...
1 October 2025 - The October 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
24 September 2025 - New Zealanders living with multiple sclerosis, breast cancer, eye conditions, and lung cancer could benefit from ...
17 September 2025 - PHARMAC is seeking feedback on a proposal to fund a new brand of methylphenidate to help ...
1 September 2025 - The September 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
11 August 2025 - Pharmac will simplify the criteria for people accessing COVID-19 anti-viral medicines and will align the funding ...
1 August 2025 - - The August 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in ...